data.hpv_distribution: Relative contribution of HPV 16/18/31/33/45/52/58 in ICC...

In lshtm-vimc/prime: PRIME -- Papillomavirus Rapid Interface for Modelling and Economics

Relative contribution of HPV 16/18/31/33/45/52/58 in ICC HPV-positive cases

Description

A dataset containing relative contribution of HPV 16/18/31/33/45/52/58 in cases of ICC HPV-positive, by region and country

Usage

data.hpv_distribution

Format

A data table with 249 observations of 39 variables.

Global

World

Region

UN region

Subregion

UN subregion

Intermediate_region

UN intermediate region

Country

Country name

iso3

ISO3 country code

hpv_4v

Relative contribution (%) of HPV 16/18 in ICC HPV-positive cases (mean)

hpv_4v_low

Relative contribution (%) of HPV 16/18 in ICC HPV-positive cases (lower bound of 95% uncertainty interval)

hpv_4v_high

Relative contribution (%) of HPV 16/18 in ICC HPV-positive cases (upper bound of 95% uncertainty interval)

hpv_9v

Relative contribution (%) of HPV 16/18/31/33/45/52/58 in ICC HPV-positive cases (mean)

hpv_9v_low

Relative contribution (%) of HPV 16/18/31/33/45/52/58 in ICC HPV-positive cases (lower bound of 95% uncertainty interval)

hpv_9v_high

Relative contribution (%) of HPV 16/18/31/33/45/52/58 in ICC HPV-positive cases (upper bound of 95% uncertainty interval)

hpv_16

Relative contribution (%) of HPV 16 in ICC HPV-positive cases (mean)

hpv_16_low

Relative contribution (%) of HPV 16 in ICC HPV-positive cases (lower bound of 95% uncertainty interval)

hpv_16_high

Relative contribution (%) of HPV 16 in ICC HPV-positive cases (upper bound of 95% uncertainty interval)

hpv_18

Relative contribution (%) of HPV 18 in ICC HPV-positive cases (mean)

hpv_18_low

Relative contribution (%) of HPV 18 in ICC HPV-positive cases (lower bound of 95% uncertainty interval)

hpv_18_high

Relative contribution (%) of HPV 18 in ICC HPV-positive cases (upper bound of 95% uncertainty interval)

hpv_31

Relative contribution (%) of HPV 31 in ICC HPV-positive cases (mean)

hpv_31_low

Relative contribution (%) of HPV 31 in ICC HPV-positive cases (lower bound of 95% uncertainty interval)

hpv_31_high

Relative contribution (%) of HPV 31 in ICC HPV-positive cases (upper bound of 95% uncertainty interval)

hpv_33

Relative contribution (%) of HPV 33 in ICC HPV-positive cases (mean)

hpv_33_low

Relative contribution (%) of HPV 33 in ICC HPV-positive cases (lower bound of 95% uncertainty interval)

hpv_33_high

Relative contribution (%) of HPV 33 in ICC HPV-positive cases (upper bound of 95% uncertainty interval)

hpv_45

Relative contribution (%) of HPV 45 in ICC HPV-positive cases (mean)

hpv_45_low

Relative contribution (%) of HPV 45 in ICC HPV-positive cases (lower bound of 95% uncertainty interval)

hpv_45_high

Relative contribution (%) of HPV 45 in ICC HPV-positive cases (upper bound of 95% uncertainty interval)

hpv_52

Relative contribution (%) of HPV 52 in ICC HPV-positive cases (mean)

hpv_52_low

Relative contribution (%) of HPV 52 in ICC HPV-positive cases (lower bound of 95% uncertainty interval)

hpv_52_high

Relative contribution (%) of HPV 52 in ICC HPV-positive cases (upper bound of 95% uncertainty interval)

hpv_58

Relative contribution (%) of HPV 58 in ICC HPV-positive cases (mean)

hpv_58_low

Relative contribution (%) of HPV 58 in ICC HPV-positive cases (lower bound of 95% uncertainty interval)

hpv_58_high

Relative contribution (%) of HPV 58 in ICC HPV-positive cases (upper bound of 95% uncertainty interval)

hpv_6

Relative contribution (%) of HPV 6 in ICC HPV-positive cases (mean)

hpv_6_low

Relative contribution (%) of HPV 6 in ICC HPV-positive cases (lower bound of 95% uncertainty interval)

hpv_6_high

Relative contribution (%) of HPV 6 in ICC HPV-positive cases (upper bound of 95% uncertainty interval)

hpv_11

Relative contribution (%) of HPV 11 in ICC HPV-positive cases (mean)

hpv_11_low

Relative contribution (%) of HPV 11 in ICC HPV-positive cases (lower bound of 95% uncertainty interval)

hpv_11_high

Relative contribution (%) of HPV 11 in ICC HPV-positive cases (upper bound of 95% uncertainty interval)

Source

Serrano B, Alemany L, Tous S, Bruni L, Clifford GM, Weiss T, et al. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agents Cancer. 2012;7: 38. https://doi.org/10.1186/1750-9378-7-38

lshtm-vimc/prime documentation built on April 21, 2024, 3:21 a.m.